Cardiff University has signed an agreement with Cytox to help the company develop a genetic risk assessment tool for Alzheimer’s disease. Cardiff University says under the licence Cytox will access its IP regarding polygenic risk scoring algorithms for predicting the future onset of Alzheimer’s disease. Cytox will gain exclusive commercialisation rights to IP and know … Continue reading Agreement between Cardiff University and Cytox to tackle Alzheimer’s disease